You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pf-05212384

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, NSCLC, Ovary Cancer Trial in Bellinzona (PF-05212384, Paclitaxel, Carboplatin)

Completed
  • Breast Cancer
  • +5 more
  • PF-05212384
  • +2 more
  • Bellinzona, TI, Switzerland
    Oncology Institute of Southern Switzerland (IOSI)
May 20, 2019

Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome, Acute Myeloid Leukemia, in Relapse, de Novo Acute Myeloid

Terminated
  • Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome
  • +2 more
  • PF-05212384
  • Paris, Ile De France, France
  • +4 more
Feb 4, 2019

Advanced Cancer Trial in Worldwide (PF-05212384, PD-0325901, irinotecan)

Terminated
Has Results
  • Advanced Cancer
  • PF-05212384
  • +2 more
  • Los Angeles, California
  • +17 more
Feb 13, 2018

Endometrial Tumors Trial in Worldwide (PF-05212384)

Terminated
Has Results
  • Endometrial Neoplasms
  • PF-05212384
  • Birmingham, Alabama
  • +50 more
Dec 19, 2018

Metastatic Colorectal Cancer Trial in Worldwide (PF-05212384, irinotecan, Cetuximab)

Terminated
Has Results
  • Metastatic Colorectal Cancer
  • PF-05212384
  • +3 more
  • Bakersfield, California
  • +31 more
Dec 19, 2018

Metastatic Colorectal Carcinoma Trial in Canada, Spain, United States (PF-05212384, FOLFIRI regimen, Bevacizumab)

Terminated
Has Results
  • Metastatic Colorectal Carcinoma
  • PF-05212384
  • +3 more
  • Fullerton, California
  • +38 more
Jul 8, 2016

Healthy Trial in Ruddington Fields (PF-05212384)

Completed
  • Healthy
  • PF-05212384
  • Ruddington Fields, Nottingham, United Kingdom
    Pfizer Investigational Site
Sep 2, 2014